Arthramid® Vet 2.5% polyacrylamide hydrogel (PAAG) - The Future of Arthritis Treatment. Arthramid Vet is proven highly effective in treating non-infectious causes of joint lameness in horses, including both early and late stages of osteoarthritis (OA). After introduction to the joint, the gel becomes fully integrated into the synovium and joint capsule by a combination of cell migration and vessel ingrowth forming a thick, cushion-like membrane that increases the elasticity and tensile strength of the joint, reducing the pain and inflammation of synovitis and restoring long-lasting joint function. Arthramid Vet is the flagship product of Innovative Medical Solutions (IMS) Vet and has been developed for the Australasian, Asian and Middle East animal markets. The company is positioned as a key leader in researching, developing and promoting innovative products for the veterinary market created around a small but dedicated team of passionate people. We research and promote the best veterinary technologies from around the world for veterinarians in Australia, New Zealand, Hong Kong, Singapore, Japan, South East Asia and The Middle East.